New MIT Nanotech Fights Cancer Naturally
September 20, 2010 8:30 AM
comment(s) - last by
Harnessing the body's own defense forces to fight cancer with nanoscale technology.
In the myriad advances in treating cancer, many a nanotech study has crossed
path. This week another such study was revealed by the journal
(abstract). In the past, we’ve seen all sorts of man-made nanoparticles both acting as a force of cell destruction and as a ferry, shipping anti-tumor drugs straight to cancer cells where they can be of the most benefit. This latest method by Massachusetts Institute of Technology researchers is akin to the latter, but instead of using nanoparticles to deliver drugs, they deliver modified immune cells from the patient’s own body.
Dr. Darrell Irvine, the team leader for the MIT study, spoke optimistically of the new treatment. “What we're looking for is the extra nudge that could take immune-cell therapy from working in a subset of people to working in nearly all patients, and to take us closer to cures of disease rather than slowing progression.”
The process by which the treatment is administered
. T cells, a type of white blood cell which is involved in cell-mediated immunity, are harvested from the patient’s blood. They are then treated in such a way so that they specifically target cancer cells. The new T cells are then attached to a lipid-based nanoparticle filled with interleukins. Interleukins are a type of chemical that helps promote the growth of T cells. Finally, the T cell and interleukin-laden nanoparticles are injected back into the patient, where the T cells seek out the tumors they’ve been programmed to destroy. The interleukins help maintain a healthy T cell count to combat the cancer cells directly without causing aberrant production elsewhere in the body.
The final part here is important. Interleukin treatments have already been widely tested in cancer patients to promote cancer-fighting T cell growth, but the treatments can have devastating side effects including heart and lung failure. The targeted approach used by Irvine’s group holds the runaway T cell production process in check by only allowing those at the tumor’s area to be affected.
In a trial using mice, the treatment was found to be 100% effective. While standard T cell or T cell and interleukin treatment mice died after 75 days, the control mice died after only 25 days and the mice given the nanoparticle treatment lived on past the 100 day limit of the study.
This article is over a month old, voting and posting comments is disabled
RE: Pretty crappy side effect...
9/20/2010 12:29:04 PM
The treatment this technology is attempting to REPLACE can have devastating side effects.
Did any of us say otherwise?
"When an individual makes a copy of a song for himself, I suppose we can say he stole a song." -- Sony BMG attorney Jennifer Pariser
United Airlines Puts Boeing's 787 Dreamliner Back in Service
May 20, 2013, 2:52 PM
Obama to "Clarify" His Position on Killing Americans With Drone Strikes
May 20, 2013, 11:22 AM
High School Student Creates Storage Device that Can Charge in 20 Seconds
May 20, 2013, 6:51 AM
Obama Admin Looks to Revive Bill for Greater Media Protection in Wake of AP Controversy
May 16, 2013, 1:47 PM
Notre Dame Designs Camera to Detect Age of Bruise for Abuse Checks
May 16, 2013, 9:05 AM
Report: Climate Change Could Wash Away Historic Jamestown Site Within 100 Years
May 15, 2013, 5:39 PM
Most Popular Articles
Windows 8.1 Will Be Free; Microsoft Holds Onto Struggling ARM Variant
May 14, 2013, 2:57 PM
Google Announces "Pure" Galaxy Nexus S4 for $649, Android Updates
May 15, 2013, 1:42 PM
Bill Gates Gets Teary-Eyed While Discussing Steve Jobs, Shows Off Life-Saving Tech on 60 Minutes
May 13, 2013, 12:30 PM
U.S. Federal Traffic Board Wants to Make Drunk Driving Threshold Far Harsher
May 15, 2013, 11:32 AM
Google's Eric Schmidt: "Don't Be Evil" was Stupid
May 14, 2013, 11:00 AM
Latest Blog Posts
Quick Note: Sony "Teases" PS4 Ahead of Xbox Reveal in New Video
May 20, 2013, 12:33 PM
Nokia Introduces Instagram-Like App of Its Own to Help Lumia Sales
May 20, 2013, 7:10 AM
Parents of Pre-Teen Drivers Commonly Practice Distracted Driving Says Study
May 9, 2013, 7:16 AM
Apple's iOS 7 Running Into Internal Delays Due to Massive Overhaul
May 1, 2013, 4:26 PM
Elon Musk Willing to Spend More Money on Widening of 405 Freeway
Apr 26, 2013, 7:28 PM
More Blog Posts
Copyright 2013 DailyTech LLC. -
Terms, Conditions & Privacy Information